中(zhong)證網訊(記者 康書偉)山東赫達今日(ri)刊登招(zhao)股(gu)說明(ming)書。根據公(gong)告(gao),公(gong)司(si)擬向社會公(gong)開發行不超過2398萬股(gu)人民幣普通股(gu),募(mu)集資金(jin)在扣除發行費用后,將按(an)照輕重緩急(ji)順序投資于“4000噸/年(nian)纖(xian)維(wei)素(su)醚(mi)項(xiang)目(mu)(醫藥(yao)級)”、“20000噸/年(nian)的纖(xian)維(wei)素(su)醚(mi)項(xiang)目(mu)(建(jian)(jian)材級)一期工程(設計產能10000噸/年(nian))”、“技術研發中(zhong)心建(jian)(jian)設項(xiang)目(mu)”及“補充(chong)公(gong)司(si)流動資金(jin)”等項(xiang)目(mu),預(yu)計使(shi)用募(mu)集資金(jin)20614.77萬元。
據測算,募(mu)投項目(mu)(不(bu)含(han)補(bu)充流動資金(jin))每年(nian)平(ping)均(jun)將為(wei)(wei)公司新(xin)增銷售收入約49990.29萬(wan)元、新(xin)增利潤總額5173.53萬(wan)元。值得注意的是,為(wei)(wei)抓住(zhu)市(shi)場(chang)機會,公司通過自(zi)籌(chou)資金(jin)先期(qi)投資本次募(mu)集資金(jin)投資項目(mu)。其(qi)中年(nian)產4000噸纖維(wei)素醚(mi)項目(mu)(醫藥級(ji))已(yi)于2013年(nian)10月(yue)投產,年(nian)產2萬(wan)噸纖維(wei)素醚(mi)項目(mu)(建材級(ji))一期(qi)工程已(yi)于2014年(nian)3月(yue)投產。
資(zi)料顯(xian)示,山東赫達是國內非離子型纖維素醚的主要(yao)(yao)生(sheng)產(chan)(chan)廠(chang)家,產(chan)(chan)品(pin)主要(yao)(yao)應(ying)用(yong)(yong)(yong)于(yu)建材領(ling)域(yu)、醫(yi)藥(yao)、食(shi)品(pin)等(deng)領(ling)域(yu)。公司(si)在2010年研發成(cheng)功了藥(yao)品(pin)緩控(kong)釋專用(yong)(yong)(yong)HPMC(CR級)并開始批(pi)量生(sheng)產(chan)(chan),目前,公司(si)的緩控(kong)釋專用(yong)(yong)(yong)HPMC(CR級)已(yi)經通過了國內多家廠(chang)家評審合格并開始批(pi)量供貨。此(ci)外,公司(si)還擁有植物(wu)膠囊專用(yong)(yong)(yong)HPMC、羥乙基(ji)長鏈(lian)疏(shu)水(shui)性(xing)改性(xing)羧甲基(ji)醚、藥(yao)用(yong)(yong)(yong)包(bao)衣輔料用(yong)(yong)(yong)HPMC、食(shi)品(pin)添加劑(ji)甲基(ji)纖維素等(deng)十多項技術儲備品(pin)種,有助(zhu)于(yu)優化公司(si)產(chan)(chan)品(pin)結構(gou),保持技術領(ling)先(xian)優勢,持續提升盈(ying)利能(neng)力。
中(zhong)(zhong)(zhong)證(zheng)網(wang)(wang)聲明:凡本(ben)(ben)網(wang)(wang)注明“來(lai)源(yuan):中(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)券報(bao)·中(zhong)(zhong)(zhong)證(zheng)網(wang)(wang)”的所有作品(pin),版權均(jun)屬于中(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)券報(bao)、中(zhong)(zhong)(zhong)證(zheng)網(wang)(wang)。中(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)券報(bao)·中(zhong)(zhong)(zhong)證(zheng)網(wang)(wang)與作品(pin)作者(zhe)聯(lian)合聲明,任何組織未經(jing)中(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)券報(bao)、中(zhong)(zhong)(zhong)證(zheng)網(wang)(wang)以及作者(zhe)書面授權不(bu)得轉載、摘編或利用其(qi)(qi)它(ta)方式使(shi)用上述(shu)作品(pin)。凡本(ben)(ben)網(wang)(wang)注明來(lai)源(yuan)非中(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)券報(bao)·中(zhong)(zhong)(zhong)證(zheng)網(wang)(wang)的作品(pin),均(jun)轉載自其(qi)(qi)它(ta)媒體,轉載目的在(zai)于更(geng)好服(fu)務讀者(zhe)、傳遞信(xin)息之需,并(bing)不(bu)代表本(ben)(ben)網(wang)(wang)贊同(tong)其(qi)(qi)觀點,本(ben)(ben)網(wang)(wang)亦不(bu)對其(qi)(qi)真實性負(fu)責,持(chi)異議者(zhe)應與原出(chu)處單(dan)位主張權利。
特別鏈接:政府部門交易機構證券期貨四所兩司新聞發布平臺友情鏈接版權聲明
關于報社關于本站廣告發布免責條款
中國證券報社版權所有,未經書面授權不得復制或建立鏡像 經營許可證編號:京B2-20180749 京公網安備0-1
Copyright 2001-2018 China Securities Journal. All Rights Reserved
中國證(zheng)券報社版(ban)權所有,未經(jing)書面授(shou)權不得復制或建立鏡(jing)像(xiang)
經營許可證編(bian)號:京B2-20180749 京公網安備0-1
Copyright 2001-2018 China Securities Journal. All Rights Reserved